No Data
No Data
Strong Week for Alcidion Group (ASX:ALC) Shareholders Doesn't Alleviate Pain of Three-year Loss
Alcidion Logs AU$10 Million Cash Receipts in Fiscal Q3
Alcidion (ASX:ALC) logged AU$10.2 million in cash receipts in the fiscal third quarter ended March, according to a Thursday filing with the Australian Securities Exchange. Further, the healthcare tech
Alcidion Group Extends Contract With Dartford and Gravesham NHS Trust; Shares Down 4%
Healthcare technology company Alcidion Group (ASX:ALC) signed a three-year contract extension with Dartford and Gravesham NHS Trust for use of its Miya Precision platform and associated modules, accor
Alcidion's Cost Cuts Make Sense to Bell Potter -- Market Talk
2315 GMT - Healthcare-software provider Alcidion's decision to cut staff looks prudent to Bell Potter analyst Thomas Wakim. The Australia-listed company announced further cost cuts in response to pers
Alcidion Price Target Cut 38% to A$0.05/Share by Bell Potter
Alcidion Price Target Cut 38% to A$0.05/Share by Bell Potter
Alcidion Group Limited (ASX:ALC) Analysts Are More Bearish Than They Used To Be
No Data